Overview

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

Status:
Completed
Trial end date:
2017-11-27
Target enrollment:
Participant gender:
Summary
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Jeil Pharmaceutical Co., Ltd.
Treatments:
Amlodipine
Rosuvastatin Calcium
Telmisartan
Telmisartan amlodipine combination